All Q4 FY25 results →
V(

Venkys (India) Ltd

Q4 FY25Food Products

Venkys (India) Q4 FY25 earnings call: Revenue & Margins

Q4 FY25 earnings call: what management guided on revenue, margins and order book.

Price₹1,507
Market cap₹2.2K Cr
P/E12.4
Updated23 Aug 2026
Read5 min read

The short version

Poultry segment is expected to grow 5%-10% in volume for FY '26 with improved realizations. Poultry segment revenue expected to grow by around 5% to 10% in FY '26 with better realization anticipated (Vijay Tijare, Page 7). - Animal Health segment projected to grow at approximately 20% in FY '26, building on consistent past growth (Deepak Khosla, Pages 7, 18). - Oilseed segment profitability expected to improve with stable soya prices; however, not likely to reach past peak EBIT levels (J.K.

From Venkys (India) Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Poultry segment is expected to grow 5%-10% in volume for FY '26 with improved realizations.
  • Animal Health (AHP) segment targets around 15%-20% growth; INR 340 crores revenue expected in FY '25 with 15% growth guidance for FY '26.
  • Expansion in SPF eggs capacity by 40,000 bird placements ongoing; potential for increased output if demand materializes.
  • Processed food (ready-to-eat/cook) segment growth projected at 25%-30% next year.
  • Soybean segment expects about 25% growth after degrowth last year.
  • New products and export initiatives underway to drive consistent and futuristic growth.

2 more points from Venkys (India) Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Venkys (India) Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • INR 70 crores capex planned for SPF (Specific Pathogen Free) egg expansion; expected to complete in about 1 year and take 2 years to reach full production. Current SPF capacity utilization is 60-65%; expansion will add capacity of around 40,000 birds annually.
  • New animal health plant commissioned recently, operating at 55-60% capacity; exploring new product lines, expected to improve margins and contribute to 20% revenue growth in AHP segment for FY '26.
  • Strategic initiatives include starting production of ready-to-cook spices in the next quarter, targeting both local and export markets with authentic Indian taste products.

2 more points from Venkys (India) Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Food Products

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
2Hoac Foods
Rev 1Mar 1
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Venkys (India) Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • The transcript does not provide explicit details on the current or expected order book or pending orders for Venky's (India) Limited.
  • However, there is an indication that the company is optimistic about growth in various segments like Animal Health (AHP), ready-to-cook/ready-to-eat processed foods, and exports.
  • New product innovations and expansion (e.g., SPF egg capacity, processed food division) suggest an expected positive order inflow.
  • The company launched new product lines and markets through QSR, retail, and e-commerce, expecting 25-30% sales growth next year.

2 more points from Venkys (India) Ltd's call on order book

Pro opens every point from 15K+ earnings calls

Venkys (India) Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹1.1K Cr, net profit ₹101 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Venkys (India) Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Venkys (India) Ltd Q4 FY25 results?

Poultry segment is expected to grow 5%-10% in volume for FY '26 with improved realizations. Poultry segment revenue expected to grow by around 5% to 10% in FY '26 with better realization anticipated (Vijay Tijare, Page 7). - Animal Health segment projected to grow at approximately 20% in FY '26, building on consistent past growth (Deepak Khosla, Pages 7, 18). - Oilseed segment profitability expected to improve with stable soya prices; however, not likely to reach past peak EBIT levels (J.K.

What is Venkys (India) Ltd share price analysis?

Venkys (India) Ltd currently shows a neutral. The stock trades at a P/E of 12.4 with a market cap of ₹2,153 Cr. Investors should review the full earnings analysis for detailed insights.

Is Venkys (India) Ltd planning capital expenditure?

INR 70 crores capex planned for SPF (Specific Pathogen Free) egg expansion; expected to complete in about 1 year and take 2 years to reach full production.

Keep Venkys (India) Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.